Safety, Pharmacokinetics, and Pharmacodynamics of Osivelotor for Sickle Cell Disease: First-in-Human Studies in Healthy Participants and Patients
奥西洛托治疗镰状细胞病的安全性、药代动力学和药效学:健康受试者和患者的首次人体研究
期刊:Clinical Pharmacology & Therapeutics
影响因子:5.5
doi:10.1002/cpt.70028
Lisbon, Eleanor A; Brown, R Clark; Redfern, Andrew; Duchin, Ken; Barth, Aline; Roberts, Erika S; Gaputan, Polo; Dufu, Kobina; Lo, Arthur; Pochron, Mira Patel; Archer, David R; Chin, Wai; Kong, Karena; Washington, Carla B; Adenola, Adeyemi; Zimmerman, Eric I